Surface Oncology, Inc. (SURF) Stock on a Rally in Premarket
Surface Oncology, Inc. (SURF), a clinical-stage immuno-oncology company, has seen an increase of 13.14% in the premarket trading session. As a result, SURF stock is changing hands at $6.80 at the moment. There appears to be no specific reason for this development. On Thursday, SURF stock closed the day at $6.01 after a steady increase […]
Surface Oncology, Inc. (SURF) Stock on a Rally in Premarket Read More »